Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO)

Infection

Volumn 33, Issue 5-6, 2005, Pages 309-313

  Kluytmans VandenBergh, M F Q ^a   Kluytmans, J A J W ^a   Voss, A ^b  

^a AMPHIA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GLYCOPEPTIDE; METICILLIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; CLINICAL PROTOCOL; DISEASE TRANSMISSION; DRUG CONTROL; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; NONHUMAN; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECIUM; HEALTH POLICY; NETHERLANDS; PRACTICE GUIDELINES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 27644511622     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-005-5079-z     Document Type: Review

References (16)

1. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
2. Shannon KP, French GL: Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000. J Antimicrob Chemother 2004; 53: 818-825.
3. Hoogkamp-Korstanje JA, Roelofs-Willemse J; Susceptibility Surveillance Study Group: Antimicrobial resistance in Gram-negative bacteria from intensive care units and urology services. A nationwide study in The Netherlands 1995-2000. Int J Antimicrob Agents 2003; 21: 547-556.
4. Glupczynski Y, Delmee M, Goossens H, Struelens M; Belgian Multicenter ICU Study Group: Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg 2001; 56: 297-306.
5. Tiemersma EW, Bronzwaer SLAM, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N, Monen J, Witte W, Grundmann H, and European Antimicrobial Resistance Surveillance System participants: Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
6. Stosor V, Peterson L, Postelnick M, Noskin G: Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158: 522-527.
7. Abramson MA, Sexton DJ: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20: 408-411.
8. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18: 275-291.
9. Garner JS, Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17: 53-80.
10. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386.
11. Dutch Working Party on Infection Prevention: Policy for methicillin-resistant Staphylococcus aureus. 2004. Available at: http:// www.wip.nl/UK/contentbrowser/onderwerpsort.asp.
12. Vandenbroucke-Grauls CM: Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996; 17: 512-513.
13. Dutch Working Party on Infection Prevention: Policy for highly-resistant microorganisms. 2004. http://www.wip.nl/UK/contentbrowser/onderwerpsort.asp
14. Dutch Working Party on Infection Prevention: Contact isolation. 2001. Available at: http://www.wip.nl/UK/contentbrowser/ onderwerpsort.asp.
15. Dutch Working Party on Infection Prevention: Droplet isolation. 2001. Available at: http://www.wip.nl/UK/contentbrowser/ onderwerpsort.asp.
16. Dutch Working Party on Infection Prevention: Strict isolation. 2001. Available at: http://www.wip.nl/UK/contentbrowser/ onderwerpsort.asp.